| |
|
|
| |
Autoimmune Disease Therapeutics to
2016
Targets, Technologies, Therapies, Markets
and Opportunities
|
Publication: May 2012
Product Code: TDA639W
|
As a group, autoimmune diseases represent one of the most
intractable families of conditions facing medical science.
The complexities and genetic underpinnings of the human
immune response result in a set of disease targets that are
at once physiologically ubiquitous and highly
individualized. Until recently, autoimmune disease patients
were given little hope for an effective treatment. But the
convergence an of improved understanding of autoimmune
disease mechanisms and the availability of recombinant
cytokines has led to systemic treatments that, while not
devoid of side effects, have demonstrated the ability to
control autoimmune reactions in a significant number of
patients. A number of potentially important pipeline drugs
hold the promise of future improvements in outcomes for
autoimmune disease patients. This study analyzes current
autoimmune therapeutics and assesses the next-generation of
candidates and their probable impact on treatment options
and the competitive landscape. |
|
Highlights |
· Analyzes current
therapeutic options for autoimmune diseases, and
evaluates emerging therapeutic candidates and assesses
their commercial potential
· Assesses existing and
evolving immune disease mechanisms and treatment
strategies
· Analyzes more than two
dozen existing and emerging autoimmune disease targets
and target-specific therapeutic drug products
· Evaluates regional and
global opportunities for autoimmune therapeutics
· Provides market data and
forecasts for six major autoimmune
disease segments to 2016
|
|
Summary of Contents |
Executive Summary
Autoimmune Therapeutics
Segment Dynamics
Sector Market Dynamics
Patient Demographics and Growth
Chronic Disease
and Self-administration
Managed Care and
Prescribing Trends
Factors Limiting Growth
Industry Alignment and Competitive Landscape
Autoimmune Therapeutic Market Assessments
Arthritis
Disease Forms and Immune Mechanisms
Therapeutic Strategies
Disease Demographics
and Growth
Key Approved Therapies
Development-stage Candidate Assessment
Market
Factors
Commercial Outlook and Forecasts
Crohn’s Disease
Disease Incidence and
Demographics
Current Generation Treatment Options
Therapies in Development
Market Factors
Commercial Outlook and Forecasts
Diabetes
Restoring Islet Cell Function
Therapies in
Development
Commercial Outlook and Forecasts
Lupus
The Ongoing Unmet Need
Pipeline
Candidates – A Ray of Hope
Market Factors
The
Potential for a Lupus-specific Therapy
Commercial
Outlook and Forecasts
Multiple Sclerosis
Disease Mechanisms and Therapeutic Strategies
The
Market Opportunity
Competitive Landscape
Development-stage Candidate Assessment
Market
Factors
Commercial Outlook and Forecasts
Psoriasis
Therapeutic Options and Expanded
Indications
Prescribing Trends and Drug Efficacy
Market Sector Factors
Development-stage Candidate
Assessment
Commercial Outlook and Forecasts
Market Factors
Risk Factors
Clinical
Trial Factors
Product Issues
Autoimmune
Therapeutics – Company Profile
|
|
|
|
|
